Screening Assay for Inhibitors of Severe Acute Respiratory Syndrome (SARS) Using SELDI-TOF Mass Spectrometry

Khalid M. Elased, Mariana Morris

Research output: Other contribution

Abstract

Mass spectrometric methods directed to screening libraries of compounds for agents that inhibit entry of Severe Acute Respiratory Syndrome (SARS) coronavirus (CoV) into cells are provided, along with methods for comparatively evaluating inhibitors of the SARS CoV.

Original languageAmerican English
StatePublished - Nov 16 2006

Keywords

  • Mass spectrometry
  • Patents
  • SARS
  • Severe acute respiratory syndrome
  • US20060257861 A1

Disciplines

  • Chemicals and Drugs
  • Medical Toxicology
  • Medicine and Health Sciences

Cite this